Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,003 public trials 2,033 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Active, not recruiting

A Study of Zilovertamab Vedotin (MK-2140) in Combination With Cyclophosphamide, Doxorubicin, and Prednisone Plus Rituximab or Rituximab Biosimilar (Truxima) (R-CHP) in Participants With Diffuse Large B-Cell Lymphoma (DLBCL) (MK-2140-007)

NCT05406401

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations
  • BC Cancer Victoria-Clinical Trials Unit ( Site 0105) Victoria, British Columbia, Canada
  • William Osler Health System ( Site 0106) Toronto, Ontario, Canada
  • Hopital du Sacre-Coeur de Montreal ( Site 0108) Montreal, Quebec, Canada
  • Hadassah Medical Center ( Site 0401) Jerusalem, Israel
View all 22 locations
View Trial Details
Active, not recruiting

Selinexor, Daratumumab, Carfilzomib and Dexamethasone for the Treatment of High-Risk, Recurrent or Refractory Multiple Myeloma

NCT04756401

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • State University of New York Upstate Medical University Syracuse, New York, United States
  • UNC Lineberger Comprehensive Cancer Center University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
  • Carolinas Medical Center/Levine Cancer Institute Charlotte, North Carolina, United States
View Trial Details
Active, not recruiting

Blinatumomab Added to Prephase and Consolidation Therapy in Precursor B-acute Lymphoblastic Leukemia in Adults.

NCT03541083

Conditions
ALL, Adult, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • BE-Antwerpen Edegem-UZA Antwerp, Belgium
  • BE-Antwerpen-ZNASTUIVENBERG Antwerp, Belgium
  • BE-Brugge-AZBRUGGE Bruges, Belgium
  • BE-Gent-UZGENT Ghent, Belgium
View all 18 locations
View Trial Details
Active, not recruiting

Project Baseline Health Study

NCT03154346

Conditions
ALL, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Baseline Study South San Francisco, California, United States
  • Stanford Medicine Stanford, California, United States
  • California Health and Longevity Institute Westlake Village, California, United States
  • Duke University School of Medicine Durham, North Carolina, United States
View Trial Details
Active, not recruiting

Ixazomib in the Prophylaxis of Chronic Graft-versus-host Disease.

NCT03225417

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • ICO- Hospital Germans Trias i Pujol Badalona, Spain
  • Hospital Clinic de Barcelona Barcelona, Spain
  • Hospital de la Santa Creu I Sant Pau Barcelona, Spain
  • Hospital Universitario Vall D´Hebrón Barcelona, Spain
View Trial Details

Related conditions